We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Point-of-Care Capillary Whole Blood Hematocrit and Hemoglobin Compared

By LabMedica International staff writers
Posted on 14 Jun 2015
The clinical suitability of point-of-care devices for conductivity based point-of-care hematocrit with calculated hemoglobin necessitates that they be accurate and that the results are interchangeable with central laboratory methods.

The appropriateness of conductivity based assays in certain patient populations, such as patients on cardiopulmonary bypass and those receiving high volumes of intravenous fluids or autologous blood transfusions, has been questioned. More...


Clinical laboratory scientists at Massachusetts General Hospital (Boston, MA, USA) performed hematocrit and hemoglobin analysis on 225 clinical samples obtained from intensive care units and the cardiac surgery operating room. All samples were from adult patients over 18 years of age. The samples were first tested for clinical care and then immediately handed off to technologists for the study testing.

The total hemoglobin level was first measured by co-oximetry on the Siemens RAPIDLab 1265 analyzer (Siemens Medical Solutions USA, Inc.; Malvern, PA, USA). Hematocrit and hemoglobin values were obtained on the Abbott i-STAT instrument using one lot of i-STAT E3+ cartridges (Abbott Point of Care; Princeton, NJ, USA). Hemoglobin values from the i-STAT are performed by the calculation of directly measured hematocrit in percent × 0.34. A manual spun hematocrit was performed on each sample as the standard hematocrit reference method. The hematocrit and hemoglobin were also determined on the automated hematology analyzer XE5000 (Sysmex Corporation; Kobe, Japan) by impedance based cumulative pulse height detection and by photometric determination, respectively.

The i-STAT hematocrit and hemoglobin showed close agreement to comparison methods with minimal bias. Median test results were not clinically or statistically different between those measured on the i-STAT and those measured using the manual spun hematocrit reference method or the Sysmex photometric hemoglobin method. The results on the i-STAT were statistically significantly different from those obtained on the Sysmex for hematocrit and the Siemens RAPIDLab co-oximeter for hemoglobin.

The authors concluded that the i-STAT hematocrit and hemoglobin performs well when compared to the hematocrit reference method and other common methods for both hematocrit and hemoglobin. Some differences between non-reference methods may be observed, but these were not considered clinically significant. The study was published in the June 2015 issue of the journal Clinica Chimica Acta.

Related Links:

Massachusetts General Hospital 
Siemens Medical Solutions USA 
Abbott Point of Care 



Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
Portable Electronic Pipette
Mini 96
New
Gold Member
Automatic Hematology Analyzer
DH-800 Series
New
Gold Member
Cardiovascular Risk Test
Metabolic Syndrome Array I & II
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The nanotechnology-based liquid biopsy test could identify cancer at its early stages (Photo courtesy of 123RF)

2-Hour Cancer Blood Test to Transform Tumor Detection

Glioblastoma and other aggressive cancers remain difficult to control largely because tumors can recur after treatment. Current diagnostic methods, such as invasive biopsies or expensive liquid biopsies,... Read more

Pathology

view channel
Image: An adult fibrosarcoma case report has shown the importance of early diagnosis and targeted therapy (Photo courtesy of Sultana and Sailaja/Oncoscience)

Accurate Pathological Analysis Improves Treatment Outcomes for Adult Fibrosarcoma

Adult fibrosarcoma is a rare and highly aggressive malignancy that develops in connective tissue and often affects the limbs, trunk, or head and neck region. Diagnosis is complex because tumors can mimic... Read more

Technology

view channel
Image: Conceptual design of the CORAL capsule for microbial sampling in the small intestine (H. Mohammed et al., Device (2025). DOI: 10.1016/j.device.2025.100904)

Coral-Inspired Capsule Samples Hidden Bacteria from Small Intestine

The gut microbiome has been linked to conditions ranging from immune disorders to mental health, yet conventional stool tests often fail to capture bacterial populations in the small intestine.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.